Literature DB >> 224232

Histopathological factors predictive for prognosis of lung cancer.

T Yoshida, T Shirakusa, N Shigematsu, Y Ushijima, K Inokuchi.   

Abstract

This study was done on 110 lung cancer patients who had received surgical resection consisted of two groups; one group of 43 who survived more than 5 years without recurrence and the other group of 67 who died within one year following surgery. Prognostic significance of the histopathological features at the primary tumor site as well as the regional lymph nodes were compared between the two groups. Blood vessel invasion by the tumor and lymph node metastasis appeared to be equally significant prognostic factors. Patients having the both factors had little chance for survival. Abundant lymphoid cell infiltration around the tumor was associated with longer survival. Lymphoid cell infiltration at the site of blood vessel invasion also was associated with better prognosis. Follicular hyperplasia and paracortical hyperplasia in the regional lymph nodes were favorable prognostic indicators, whereas sinus histocytosis was poorly significant prognostic indicator.

Entities:  

Mesh:

Year:  1979        PMID: 224232     DOI: 10.1007/bf02469423

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  12 in total

1.  The prognostic implications of vascular invasion in primary carcinomas of the lung; a clinicopathologic correlation of two hundred twenty-five cases with one hundred per cent follow-up.

Authors:  F C COLLIER; H T ENTERLINE; R H KYLE; T T TRISTAN; R GREENING
Journal:  AMA Arch Pathol       Date:  1958-10

2.  Carcinoma of the lung: factors which influence five year survival with special reference to blood vessel invasion.

Authors:  F C COLLIER; W S BLAKEMORE; R H KYLE; H T ENTERLINE; C K KIRBY; J JOHNSON
Journal:  Ann Surg       Date:  1957-09       Impact factor: 12.969

3.  Changes in T cell population in patients with bronchogenic carcinoma.

Authors:  T Shirakusa; N Shigematsu; T Yoshida; R Saito; N Katayama; K Inokuchi
Journal:  J Thorac Cardiovasc Surg       Date:  1978-08       Impact factor: 5.209

4.  Sinus histiocytosis in non-diagnostic scalene lymph node biopsies.

Authors:  S G Silverberg; W J Frable; J W Brooks
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

5.  Cellular responses to autologous breast cancer tissue. Correlation with stage and lymphoreticuloendothelial reactive.

Authors:  M M Black; H P Leis
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

6.  Prognostic significance of histologic host response in cancer of the larynx or hypopharynx.

Authors:  S H Bennett; J W Futrell; J A Roth; R C Hoye; A S Ketcham
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

7.  Mesocolic lymph node histology is an important prognostic indicator for patients with carcinoma of the sigmoid colon: an immunomorphologic study.

Authors:  D J Patt; R K Brynes; J W Vardiman; L W Coppleson
Journal:  Cancer       Date:  1975-05       Impact factor: 6.860

8.  Reactive hyperplasia of paracortex and germinal centers of the regional lymph nodes in gastric carcinoma cases as a favorable prognostic indicator.

Authors:  Y Kodama; K Seojima; K Inokuchi
Journal:  Jpn J Surg       Date:  1976-03

9.  Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.

Authors:  H J Bloom; W W Richardson; J R Field
Journal:  Br Med J       Date:  1970-07-25

10.  Immune reactivity in primary carcinoma of the lung and its relation to prognosis.

Authors:  H J Wanebo; B Rao; N Miyazawa; N Martini; M P Middleman; H F Oettgen; E J Beattie
Journal:  J Thorac Cardiovasc Surg       Date:  1976-09       Impact factor: 5.209

View more
  1 in total

1.  Natural killer activity of peripheral blood lymphocytes and its relation to histopathological factors of lung cancer.

Authors:  A Terazawa; N Tanaka; N Senou; F Inoue; H Matsuura; A Gouchi; S Fuchimoto; H Mimura; K Orita
Journal:  Jpn J Surg       Date:  1987-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.